TG Therapeutics TGTX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's change in lease liabilities?
- TG Therapeutics (TGTX) reported change in lease liabilities of -$424K in Q1 2026.
- How has TG Therapeutics's change in lease liabilities changed year-over-year?
- TG Therapeutics's change in lease liabilities increased by 21.9% year-over-year, from -$543K to -$424K.
- What is the long-term trend for TG Therapeutics's change in lease liabilities?
- Over 3 years (2021 to 2025), TG Therapeutics's change in lease liabilities has grown at a 1.4% compound annual growth rate (CAGR), from -$2.01M to -$2.1M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.